查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424093

羟考酮药品市场、份额、规模、趋势、产业分析报告：按药物类型、按剂型、按分销管道、按地区、按细分市场、预测，2024-2032年

Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球羟考酮药物市场预计将达到 82.9 亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

癌症、类风湿性关节炎、腰痛和纤维肌痛等慢性疼痛疾病盛行率的上升是羟考酮市场扩张的主要驱动力。 此外，其他药物在治疗严重疼痛方面表现出的反应性增加了对羟考酮药剂的需求。 此外，这些药物的有希望的结果以及与缓释羟考酮药物製剂相关的益处增加了它们的处方量。 此外，羟考酮药物的卓越依从性和短给药间隔的便利性可能会推动未来几年的市场成长。

此外，缓释胶囊的推出和成人剧烈疼痛的高盛行率也推动了市场成长。 此外，市场进入者持有的专利数量的增加以及行销和促销支出的增加预计将有助于市场成长。 例如，Collegium Pharmaceuticals 的 Xtampza ER 的专利保护期至 2036 年。

羟考酮製剂也推动了市场成长，与其他鸦片类製剂相比，羟考酮製剂显示出有希望的结果。 此外，随着药物传递系统的进步，新药的出现，例如缓释製剂，可能为羟考酮药品市场的成长提供长期机会。 羟考酮缓解手术后剧烈疼痛的能力，加上外科手术的增加，预计将支持市场扩张。

羟考酮作为止痛药物的广泛接受度以及手术后疼痛管理对羟考酮的需求不断增长是推动市场成长的因素。 此外，公司对未开发市场监管审批的强烈关注也将对市场成长产生正面影响。 此外，缺乏身体活动、吸烟和肥胖导致越来越多的患者遭受慢性疼痛。 例如，根据世界肥胖联合会的《2023 年世界肥胖地图集》报告，预计全球超重或肥胖人数将从 2020 年的 26 亿增加到 40 亿。 这些需要止痛药物的肥胖者可能会在预测期内推动市场成长。

羟考酮药品市场报告重点

长效细分市场因其在改善疼痛管理和减少疼痛强度变化方面的优势而占据市场主导地位。

随着缓释胶囊的出现，胶囊细分市场预计将以最高复合年增长率扩张。

由于外科手术和住院人数的增加，医院部门占据了最大的市场份额。

北美由于羟考酮处方量大和慢性疼痛状况增加而主导市场。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球羟考酮药物市场洞察

  • 羟考酮药品市场 - 通路概况
  • 羟考酮药物市场动态
    • 促进因素和机会
      • 慢性疼痛发生率的上升预计将支持羟考酮市场的扩张
      • 羟考酮药物成本的增加为市场成长提供了长期机会
    • 抑制因素和挑战
      • 羟考酮的多项风险和严格监管预计将阻碍市场成长
  • PESTEL 分析
  • 羟考酮药品市场通路趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球羟考酮药物市场（依药物类型）

  • 主要发现
  • 简介
  • 短效
  • 长效

第 6 章全球羟考酮药物市场（以剂型）

  • 主要发现
  • 简介
  • 锭
  • 胶囊
  • 注射

第 7 章全球羟考酮药品市场（依通路）

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

第 8 章全球羟考酮药品市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年羟考酮药品市场评估（按地区）
  • 羟考酮药品市场 - 北美
    • 北美：羟考酮药物市场（以药物类型），2019-2032 年
    • 北美：羟考酮药品市场，依通路划分，2019-2032 年
    • 北美：羟考酮药品市场，按剂型，2019-2032 年
    • 羟考酮药品市场 - 美国
    • 羟考酮药品市场 - 加拿大
  • 羟考酮药品市场 - 欧洲
    • 欧洲：羟考酮药物市场（以药物类型），2019-2032 年
    • 欧洲：羟考酮药品市场，依通路划分，2019-2032 年
    • 欧洲：羟考酮药品市场（按剂型），2019-2032 年
    • 羟考酮药品市场 - 英国
    • 羟考酮药品市场 - 法国
    • 羟考酮药品市场 - 德国
    • 羟考酮药品市场 - 义大利
    • 羟考酮药品市场 - 西班牙
    • 羟考酮药品市场 - 荷兰
    • 羟考酮药品市场 - 俄罗斯
  • 羟考酮药品市场 - 亚太地区
    • 亚太地区：羟考酮药物市场（以药物类型），2019-2032 年
    • 亚太地区：羟考酮药品市场，依通路划分，2019-2032 年
    • 亚太地区：羟考酮药品市场，按剂型，2019-2032 年
    • 羟考酮医药市场 - 中国
    • 羟考酮药品市场 - 印度
    • 羟考酮药品市场 - 马来西亚
    • 羟考酮药品市场 - 日本
    • 羟考酮药品市场 - 印度尼西亚
    • 羟考酮药品市场－韩国
  • 羟考酮药品市场 - 中东和非洲
    • 中东和非洲：羟考酮药物市场（按药物类型），2019-2032 年
    • 中东和非洲：羟考酮药品市场，依通路划分，2019-2032 年
    • 中东和非洲：羟考酮药品市场，按剂型，2019-2032 年
    • 羟考酮药品市场 - 沙乌地阿拉伯
    • 羟考酮药品市场 - 阿拉伯联合大公国
    • 羟考酮药品市场 - 以色列
    • 羟考酮药品市场 - 南非
  • 羟考酮药品市场 - 拉丁美洲
    • 拉丁美洲：羟考酮药物市场（以药物类型），2019-2032 年
    • 拉丁美洲：羟考酮药品市场，依通路划分，2019-2032 年
    • 拉丁美洲：羟考酮药品市场，按剂型，2019-2032 年
    • 羟考酮药品市场 - 墨西哥
    • 羟考酮药品市场 - 巴西
    • 羟考酮药品市场 - 阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • Acura Pharmaceuticals（U.S.）
  • Alvogen（U.S.）
  • Amneal Pharmaceuticals LLC.（U.S.）
  • Ascent Pharmaceuticals, Inc.（U.S.）
  • Collegium Pharmaceutical（U.S.）
  • Endo International plc（Ireland）
  • Epic Pharma, LLC.（U.S.）
  • Mallinckrodt（Ireland）
  • Mundipharma International（UK）
  • Pfizer Inc.（U.S.）
  • Protega Pharmaceuticals Inc.（U.S.）
  • Rhodes Pharmaceuticals L.P.（U.S.）
  • Sun Pharmaceutical Industries Ltd.（India）
Product Code: PM4347

The global oxycodone drugs market size is expected to reach USD 8.29 billion by 2032, according to a new study by Polaris Market Research. The report "Oxycodone Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Short-acting, Long-acting); By Dosage Form; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising incidence of chronic pain disease such as cancer, rheumatoid arthritis, lower back pain, and fibromyalgia is the primary contributor for the oxycodone market expansion. Moreover, the unresponsiveness shown by other medications for the treatment of severe pain management has increased the demand for oxycodone drugs. Furthermore, promising results of these drugs and benefits associated with the extended release oxycodone drugs has increased its prescription volumes. Additionally, better compliance and convenience of less-frequent dosage intervals offered by oxycodone drugs will fuel the market growth in the coming years.

The advent of extended-release capsules coupled with the high prevalence of severe pain among adults are also propelling the market growth. Moreover, the patents owned by market players coupled with their increasing expenses on marketing and promotion will contribute to the market growth. For instance, Collegium Pharmaceutical's Xtampza ER has patent protection until 2036.

The promising results shown by the oxycodone drugs over other opioid medications is also driving the market growth. Moreover, the advent of new drugs with advancements in drug delivery systems such as extended-release formulations will provide long-term opportunity for the oxycodone drugs market growth. The ability of oxycodone to lower the severe pain after surgery coupled with an increasing number of surgical procedures are expected to support the market expansion.

The widespread acceptance of oxycodone drugs as a pain-relieving medication and growing need for oxycodone for the pain management after surgeries are the factors propelling the market growth. Moreover, the strong focus of companies on the regulatory approvals in untapped markets will positively influence the market growth. Furthermore, lack of physical activities, tobacco usage, and obesity are increasing the number of patients suffering from chronic pain. For instance, according to the World Obesity Atlas 2023 Report by the World Obesity Federation, the number of people with overweight or obesity worldwide is expected to increase to 4.0 billion, from 2.6 billion in 2020. Such obese people requiring pain management medications will drive the market growth during the forecast period.

Oxycodone Drugs Market Report Highlights

The long-acting segment dominated the market, owing to its benefits for improving pain management and reducing pain intensity variations.

The capsules segment is expected to expand at the highest CAGR, owing to the emergence of extended release capsules.

Hospital segment held the largest market share, owing to the increasing number of surgical procedures and rising hospital admissions.

North America dominated the market, owing to the large volume of oxycodone prescriptions and rising incidences of chronic pain diseases.

The market players include Collegium Pharmaceutical, Mundipharma International, Sun Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt.

Polaris Market Research has segmented the oxycodone drugs market report based on drug type, dosage form, distribution channel, and region:

Oxycodone Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Short-acting
  • Long-acting

Oxycodone Drugs, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablet
  • Capsule
  • Injection

Oxycodone Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Oxycodone Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oxycodone Drugs Market Insights

  • 4.1. Oxycodone Drugs Market - Distribution Channel Snapshot
  • 4.2. Oxycodone Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of chronic pain is expected to support the oxycodone market expansion
      • 4.2.1.2. Increasing expenses for oxycodone drugs will provide a long-term opportunity for the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Several risks of oxycodone coupled with strict regulations is expected to hamper the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Oxycodone Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oxycodone Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Short-acting
    • 5.3.1. Global Oxycodone Drugs Market, by Short-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Long-acting
    • 5.4.1. Global Oxycodone Drugs Market, by Long-acting, by Region, 2019-2032 (USD Billion)

6. Global Oxycodone Drugs Market, by Dosage Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 6.3. Tablet
    • 6.3.1. Global Oxycodone Drugs Market, by Tablet, by Region, 2019-2032 (USD Billion)
  • 6.4. Capsule
    • 6.4.1. Global Oxycodone Drugs Market, by Capsule, by Region, 2019-2032 (USD Billion)
  • 6.5. Injection
    • 6.5.1. Global Oxycodone Drugs Market, by Injection, by Region, 2019-2032 (USD Billion)

7. Global Oxycodone Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Oxycodone Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Oxycodone Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Oxycodone Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Oxycodone Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Oxycodone Drugs Market - North America
    • 8.3.1. North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.4. Oxycodone Drugs Market - U.S.
      • 8.3.4.1. U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.3.5. Oxycodone Drugs Market - Canada
      • 8.3.5.1. Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.4. Oxycodone Drugs Market - Europe
    • 8.4.1. Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.4. Oxycodone Drugs Market - UK
      • 8.4.4.1. UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.5. Oxycodone Drugs Market - France
      • 8.4.5.1. France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.6. Oxycodone Drugs Market - Germany
      • 8.4.6.1. Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.7. Oxycodone Drugs Market - Italy
      • 8.4.7.1. Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.8. Oxycodone Drugs Market - Spain
      • 8.4.8.1. Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.9. Oxycodone Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.4.10. Oxycodone Drugs Market - Russia
      • 8.4.10.1. Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.5. Oxycodone Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.4. Oxycodone Drugs Market - China
      • 8.5.4.1. China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.5. Oxycodone Drugs Market - India
      • 8.5.5.1. India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.6. Oxycodone Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.7. Oxycodone Drugs Market - Japan
      • 8.5.7.1. Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.8. Oxycodone Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.5.9. Oxycodone Drugs Market - South Korea
      • 8.5.9.1. South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.6. Oxycodone Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.4. Oxycodone Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.5. Oxycodone Drugs Market - UAE
      • 8.6.5.1. UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.6. Oxycodone Drugs Market - Israel
      • 8.6.6.1. Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.6.7. Oxycodone Drugs Market - South Africa
      • 8.6.7.1. South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • 8.7. Oxycodone Drugs Market - Latin America
    • 8.7.1. Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.4. Oxycodone Drugs Market - Mexico
      • 8.7.4.1. Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.5. Oxycodone Drugs Market - Brazil
      • 8.7.5.1. Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
    • 8.7.6. Oxycodone Drugs Market - Argentina
      • 8.7.6.1. Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Acura Pharmaceuticals (U.S.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2.Alvogen (U.S.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amneal Pharmaceuticals LLC. (U.S.)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ascent Pharmaceuticals, Inc. (U.S.)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Collegium Pharmaceutical (U.S.)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Endo International plc (Ireland)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Epic Pharma, LLC. (U.S.)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mallinckrodt (Ireland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mundipharma International (UK)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer Inc. (U.S.)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Protega Pharmaceuticals Inc. (U.S.)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Rhodes Pharmaceuticals L.P. (U.S.)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd. (India)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 2 Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 3 Global Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 6 North America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 7 North America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 10 U.S.: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 13 Canada: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 16 Europe: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 UK: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 19 UK: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 France: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 22 France: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 25 Germany: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 28 Italy: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 31 Spain: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 37 Russia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 42 China: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 43 China: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 45 India: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 46 India: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 52 Japan: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 58 South Korea: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 67 UAE: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 70 Israel: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 73 South Africa: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 76 Latin America: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 79 Mexico: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 82 Brazil: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 85 Argentina: Oxycodone Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Oxycodone Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Dosage Form
  • Figure 7. Global Oxycodone Drugs Market, by Dosage Form, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Oxycodone Drugs Market, by Drug Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Oxycodone Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Oxycodone Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Oxycodone Drugs Market